Ignite Creation Date:
2025-12-24 @ 9:42 PM
Ignite Modification Date:
2026-01-13 @ 3:25 AM
Study NCT ID:
NCT07214532
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-12-23
First Post:
2025-09-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Sponsor:
Natera, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
25-085-NCP
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None